scholarly journals COMPLIANCE WITH CLINICAL PRACTICE GUIDELINES FOR NON ST-SEGMENT ELEVATION ACUTE CORONARY SYNDROME: ASSOCIATION BETWEEN OUTCOMES AND PREDICTORS OF POOR MANAGEMENT (RECORD-3 REGISTRY DATA)

2016 ◽  
pp. 75-82 ◽  
Author(s):  
A. D. Erlikh ◽  
O. L. Barbarash ◽  
V. V. Kashtalap ◽  
N. A. Gratsiansky
Keyword(s):  
Acute Coronary Syndrome ◽  
Clinical Practice ◽  
Clinical Practice Guidelines ◽  
Practice Guidelines ◽  
Registry Data ◽  
St Segment Elevation ◽  
Coronary Syndrome ◽  
St Segment ◽  
Poor Management ◽  
Syndrome Association

scholarly journals 2020 Clinical practice guidelines for Acute coronary syndrome without ST segment elevation

2021 ◽  
Vol 26 (4) ◽  
pp. 4449
Author(s):  
Russian Society of Cardiology (RSC)
Keyword(s):  
Acute Coronary Syndrome ◽  
Clinical Practice ◽  
Russian Federation ◽  
Clinical Practice Guidelines ◽  
Practice Guidelines ◽  
Ministry Of Health ◽  
St Segment Elevation ◽  
Coronary Syndrome ◽  
St Segment ◽  
The Russian Federation

Endorsed by: Research and Practical Council of the Ministry of Health of the Russian Federation.

scholarly journals 2020 Russian and European clinical practice guidelines for the management of NSTEMI patients: have approaches to antithrombotic therapy been simplified?

2021 ◽  
Vol 10 (2) ◽  
pp. 92-101
Author(s):  
O. L. Barbarash ◽  
V. V. Kashtalap
Keyword(s):  
Clinical Practice ◽  
Anticoagulant Therapy ◽  
Clinical Practice Guidelines ◽  
Practice Guidelines ◽  
Antithrombotic Therapy ◽  
St Segment Elevation ◽  
Coronary Syndrome ◽  
St Segment ◽  
Coronary Syndromes ◽  
Esc Guidelines

Highlights. Prescribtion patterns of antithrombotic therapy in patients with non-ST-segment elevation acute coronary syndromes have been comapred in 2020 Russian and European clinical practice guidelines for the management of NSTEMI patients.A comparative assessment of novel approaches of antiplatelet and anticoagulant therapy recommended in 2020 European and Russian clinical practice guidelines for the management of patients with non-ST-segment elevation acute coronary syndrome is reported. In prescribing antiplatelet therapy, ESC guidelines suggest focusing attention on a more complex set of regimens to balance ischemic and hemorrhagic risks. Approaches to prescribing anticoagulant therapy do not differ in the recommendations of two medical societies. Fondaparinux has compelling advantages over other drugs regarding the combination of efficacy and safety in patients.

scholarly journals Results of clinical studies PLATO and place of ticagrelor in the treatment of acute coronary syndrome

2015 ◽  
Vol 6 (1) ◽  
pp. 53-59
Author(s):  
A. D Erlih
Keyword(s):  
Clinical Trial ◽  
Acute Coronary Syndrome ◽  
Clinical Practice ◽  
Randomized Clinical Trial ◽  
Study Design ◽  
Clinical Practice Guidelines ◽  
Practice Guidelines ◽  
Clinical Studies ◽  
Efficacy And Safety ◽  
Coronary Syndrome

This article provides an analysis of the results of a large international randomized clinical trial PLATO, in which to learn a new antiplatelet ticagrelor compared with clopidogrel in addition to aspirin in patients with acute coronary syndrome (ACS). Material contains a description of the study design, the main results concerning the efficacy and safety of ticagrelor. In addition, the material presented those parts of modern clinical practice guidelines, which describes the location of ticagrelor in the treatment of ACS and which are modified according to a PLATO study.

Sign in / Sign up

Export Citation Format

Share Document